Cedar Health Research, LLC | DFW-East Clinical Site
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 2 to 4 other available medications to prevent their migraines, but these medications have not helped them.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Additional protocol-defined criteria apply.
Primary purpose
Allocation
Interventional model
Masking
498 participants in 5 patient groups, including a placebo group
Loading...
Central trial contact
Email contact via H. Lundbeck A/S
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal